You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) Anticorps

The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain promoters and enhancers. De plus, nous expédions CEBPA Kits (30) et CEBPA Protéines (11) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
CEBPA 1050 P49715
CEBPA 12606 P53566
CEBPA 24252 P05554
Comment commander chez anticorps-enligne
  • +33 (0)1 76 63 32 65
  • +33 (0)1 74 18 08 22
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-CEBPA Anticorps sur anticorps-enligne.fr

Showing 10 out of 152 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Fournisseur Livraison Prix Détails
Poulet Lapin Inconjugué IHC, WB WB Suggested Anti-CEBPA Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:312500Positive Control: 721_B cell lysate 100 μL Connectez-vous pour afficher 6 to 8 Days
358,51 €
Détails
Humain Lapin Inconjugué FACS, WB Western blot analysis of CEBPA Antibody (C-term) (ABIN653431) in mouse liver tissue lysates (35 µg/lane). CEBPA (arrow) was detected using the purified polyclonal antibody. 400 μL Connectez-vous pour afficher 14 to 16 Days
335,24 €
Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-CEBPA Antibody Titration: 0.2-1 ug/mlPositive Control: HepG2 cell lysate 100 μL Connectez-vous pour afficher 6 to 8 Days
358,51 €
Détails
Humain Lapin Inconjugué EIA, FACS, WB CEBPA Antibody (C-term) flow cytometric analysis of Hela cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. Western blot analysis of CEBPA Antibody (C-term) in mouse liver tissue lysates (35µg/lane). CEBPA (arrow) was detected using the purified Pab. 0.4 mL Connectez-vous pour afficher Disponible
407,00 €
Détails
Humain Souris Inconjugué FACS, ICC, IF, IP, WB Flow Cytometry: CEBP alpha Antibody (15C8) [ABIN269606] - Flow cytometry analysis of CEBP alpha was done on THP-1 cells. Cells were fixed with 70% ethanol for 10 minutes, permeabilized with 0.25% Triton (R) X-100 for 20 minutes, and blocked with 5% BSA for 30 minutes at room temperature. Cells were labeled with CEBP alpha Mouse Monoclonal Antibody (MA1825, red histogram) or with mouse isotype control (pink histogram) at 3-5 ug/million cells in 2.5% BSA. After incubation at room temperature for 2 hours, the cells were labeled with Alexa Fluor (R) 488 Rabbit Anti-Mouse Secondary Antibody (A11059) at a dilution of 1:400 for 30 minutes at room temperature. The representative 10,000 cells were acquired and analyzed for each sample using an Attune (R) Acoustic Focusing Cytometer. The purple histogram represents unstained control cells and the green histogram represents no-primary-antibody control Western Blot: CEBP alpha Antibody (15C8) [ABIN269606] - Analysis of transfected 293T cells. 0.1 mg Connectez-vous pour afficher 3 to 5 Days
388,75 €
Détails
Humain Souris Inconjugué EIA, FACS, WB 0.1 mg Connectez-vous pour afficher 8 to 10 Days
473,00 €
Détails
Humain Souris Inconjugué ICC, FACS, IHC, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of MCF-7 cells using CEBPA mouse mAb (green) and negative control (red) . 100 μL Connectez-vous pour afficher 6 to 8 Days
494,23 €
Détails
Humain Souris Inconjugué FACS, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of HeLa cells using CEBPA mouse mAb (green) and negative control (red) . 0.1 mg Connectez-vous pour afficher 6 to 8 Days
494,23 €
Détails
Humain Lapin Inconjugué WB WB Suggested Anti-CEBPA Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:62500Positive Control: Hela cell lysate 100 μL Connectez-vous pour afficher 6 to 8 Days
358,51 €
Détails
Humain Lapin Inconjugué IHC (p), WB 0.1 mg Connectez-vous pour afficher 8 to 10 Days
385,00 €
Détails

CEBPA Anticorps par réactivité, application, clonalité et conjugué

Attributs Application Hôte Clonalité Conjugué
Human , , , ,
, , ,
,
, , , , , , , , , , , , , ,
Mouse (Murine) , ,
, ,
,
, , , , , , , , , , ,
Rat (Rattus) , ,
,
,
, , , , , , , , , , ,

anti-CEBPA Anticorps mieux référencés

  1. Human Polyclonal CEBPA Primary Antibody pour EIA, FACS - ABIN951460 : Twu, Hsieh, Lin, Tzeng, Sun, Yu: Phosphorylation status of transcription factor C/EBPalpha determines cell-surface poly-LacNAc branching (I antigen) formation in erythropoiesis and granulopoiesis. dans Blood 2010 (PubMed)
    Show all 4 references for ABIN951460

  2. Human Monoclonal CEBPA Primary Antibody pour FACS, ICC - ABIN269606 : Ferrari-Amorotti, Keeshan, Zattoni, Guerzoni, Iotti, Cattelani, Donato, Calabretta: Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha. dans Blood 2006 (PubMed)
    Show all 4 references for ABIN269606

  3. Chicken Polyclonal CEBPA Primary Antibody pour IHC, WB - ABIN2787465 : Singh, Trivedi, Behre: C/EBPalpha S248A mutation reduces granulocytic differentiation in human leukemic K562 cells. dans Biochemical and biophysical research communications 2008 (PubMed)
    Show all 3 references for ABIN2787465

  4. Human Polyclonal CEBPA Primary Antibody pour FACS, WB - ABIN653431 : Nanri, Uike, Kawakita, Iwanaga, Mitsuya, Asou: A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation. dans Genes, chromosomes & cancer 2010 (PubMed)
    Show all 3 references for ABIN653431

  5. Human Monoclonal CEBPA Primary Antibody pour FACS, ELISA - ABIN969507 : Geest, Buitenhuis, Vellenga, Coffer: Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia. dans Haematologica 2009 (PubMed)

  6. Human Monoclonal CEBPA Primary Antibody pour ICC, FACS - ABIN969048 : Jin, Zhang, Yan, Liu, Wang, Ge, Zhai: C/EBPalpha regulates SIRT1 expression during adipogenesis. dans Cell research 2010 (PubMed)

  7. Cow (Bovine) Polyclonal CEBPA Primary Antibody pour WB - ABIN2792649 : Zhu, Qian, Levy: CCAAT/enhancer-binding protein alpha (C/EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHX1) through the interaction with DNA-bound NF-Y. dans The Journal of biological chemistry 2004 (PubMed)

Plus d’anticorps contre CEBPA partenaires d’interaction

Human CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) interaction partners

  1. results demonstrate that the low-level expression of human ACAT2 gene with specific CpG-hypomethylated promoter is regulated by the C/EBP transcription factors in monocytic cells, and imply that the lowly expressed ACAT2 catalyzes the synthesis of certain CE/SE that are assembled into lipoproteins for the secretion

  2. Our study highlighted two novel promoter KLF1 and 3'-region C/EBPalpha motifs in the phenylalanine hydroxylase (PAH) gene which decrease transcription in vitro and, thus, could be considered as PAH expression modifiers.

  3. The QA repeat domain of TCERG1 (Montrer TCERG1 Anticorps) is required for relocalization of CEBPalpha.

  4. In the CCAAT/enhancer binding protein alpha gene, no mutations were detected but a known polymorphism (c.584_589dup ACCCGC) was observed in 26 (28.3%) patients.

  5. The p53 (Montrer TP53 Anticorps)-KLF4 (Montrer KLF4 Anticorps)-CEBPA axis is deregulated in AML (Montrer RUNX1 Anticorps) but can be functionally restored by conventional chemotherapy and novel p53 (Montrer TP53 Anticorps) activating treatments.

  6. C/EBPalpha inhibited breast cancer cell growth via a novel miR (Montrer MLXIP Anticorps)-134/CREB (Montrer CREB1 Anticorps) signaling pathway.

  7. C/EBP-alpha was primarily expressed in hepatocytes in normal liver, but its expression decreased significantly in liver fibrosis

  8. The efficient repression of E2F (Montrer E2F1 Anticorps) dependent S-phase genes and the activation of differentiation genes reside in the balanced DNA binding capacity of C/EBP alpha.

  9. we are the first to identify that miR (Montrer MLXIP Anticorps)-381 suppresses C/EBPalpha-dependent Cx43 (Montrer GJA1 Anticorps) expression in breast cancer cells. The miR (Montrer MLXIP Anticorps)-381-C/EBPalpha-Cx43 (Montrer GJA1 Anticorps) axis might be a useful diagnostic and therapeutic target of metastatic breast cancer

  10. results suggested that C/EBPalpha-saRNA successfully inhibited HCC (Montrer FAM126A Anticorps) metastasis by inhibiting EGFR (Montrer EGFR Anticorps)/beta-catenin (Montrer CTNNB1 Anticorps) signaling pathway mediated EMT (Montrer ITK Anticorps) in vitro and in vivo

Mouse (Murine) CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) interaction partners

  1. the DNA sequences to which EVI1 (Montrer MECOM Anticorps) binds at +35 and +37 kb and show that mutation of one of these releases Cebpa from EVI1 (Montrer MECOM Anticorps)-induced suppression.

  2. The efficient repression of E2F (Montrer E2F1 Anticorps) dependent S-phase genes and the activation of differentiation genes reside in the balanced DNA binding capacity of C/EBP alpha.

  3. Cebpa enhancers and silencers in a transcriptional model have roles in hematopoietic lineage specification

  4. Data show that CCAAT-enhancer-binding protein-alpha (C/EBPalpha) directly regulates Kruppel-like factor 4 (Klf4 (Montrer KLF4 Anticorps)) expression and increasing the levels of histone demethylase (Montrer MBD2 Anticorps) Lsd1 (Montrer KDM1A Anticorps) and transcription factor Brd4 (Montrer BRD4 Anticorps) in B cell.

  5. The findings demonstrate a critical role for the +37 kb Cebpa enhancer for hematopoietic-specific Cebpa expression, with enhancer deletion leading to impaired myelopoiesis and potentially preleukemic progenitor expansion.

  6. Data indicate that miR (Montrer MLXIP Anticorps)-25 is a novel negative regulator of adipocyte differentiation and it suppressed 3T3-L1 adipogenesis by targeting KLF4 (Montrer KLF4 Anticorps) and C/EBPalpha, which provides novel insights into the molecular mechanism of miRNA-mediated cellular differentiation.

  7. MYB (Montrer MYB Anticorps) and C/EBPalpha activities are inter-dependent in controlling Flt3 (Montrer FLT3 Anticorps) expression to influence lineage commitment of multipotential progenitors.

  8. Data indicate that white adipose tissue from IgE receptor FcR1-deficient Fcer1a (Montrer FCER1A Anticorps)(-/-) mice showed an increased expression of CCAAT-enhancer-binding protein-alpha (C-EBPalpha) and peroxisome proliferator-activated receptor-gamma (PPARgamma (Montrer PPARG Anticorps)).

  9. miR (Montrer MLXIP Anticorps)-223 regulates adipocyte and osteoblast differentiation through a novel C/EBPs/miR (Montrer MLXIP Anticorps)-223/FGFR2 (Montrer FGFR2 Anticorps) regulatory feedback loop.

  10. Data (including data from studies in transgenic/mutant mice) suggest Cebpa (CCAAT-enhancer binding protein alpha) in myeloid cells is down-regulated in type 2 diabetes resulting in poor maturation of Gr-1 (Montrer GSR Anticorps)+ (chemokine receptor (Montrer CCR1 Anticorps)) myeloid cells.

Zebrafish CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) interaction partners

  1. C/ebpalpha plays a role in liver growth regulation via the p53 (Montrer TP53 Anticorps) pathway.

  2. Dnmt1 (Montrer DNMT1 Anticorps) is required for hematopoietic stem and progenitor cells maintenance via cebpa regulation during definitive hematopoiesis in zebrafish

  3. Data suggest that upregulation of 10-formyltetrahydrofolate dehydrogenase (FDH (Montrer ALDH1L1 Anticorps)) involving CEBPalpha helps relieve embryonic oxidative stress induced (Montrer SQSTM1 Anticorps) by ethanol exposure.

  4. Bmi1 (Montrer BMI1 Anticorps) acts immediately downstream of CCAAT enhancer binding protein-alpha to regulate the survival and self-renewal of hematopoietic stem cells and contribute to the erythropoietic dysplasia.

  5. Results provide first evidence that sumoylation of Cebp-alpha (via SUMO1 (Montrer SUMO1 Anticorps), SUMO2 (Montrer SUMO2 Anticorps), and SUMO3 (Montrer SUMO3 Anticorps)) might contribute to cell fate decision of myelo-erythroid progenitor cells in intermediate cell mass during primitive [extramedullary] hematopoiesis.

  6. An evolutionarily conserved PTEN (Montrer PTEN Anticorps)-C/EBPalpha-CTNNA1 (Montrer CTNNA1 Anticorps) axis controls myeloid development and transformation.

Xenopus laevis CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) interaction partners

  1. a C/EBP recognition sequence in the proximal promoter region of C/EBPalpha is essential for IL-6 (Montrer IL6 Anticorps)-mediated repression

Cow (Bovine) CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) interaction partners

  1. These results suggest that the CEBPA gene is a strong candidate gene that affects carcass traits in Qinchuan cattle.

  2. Expressions of C-EBPalpha and myostatin (Montrer MSTN Anticorps) in muscles were higher in the concentrate-fed group than in the grass hay (Montrer GTF2H5 Anticorps)-fed group.

Pig (Porcine) CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) interaction partners

  1. C/EBPalpha is an essential regulatory factor for perilipin5 transcription and suggest that fasting stimulates perilipin5 transcription through influencing C/EBPalpha expression.

  2. The differential expression of specific CEBPA/B isoforms observed in maturing follicles and CL may contribute to changes in follicular cell differentiation and increasing steroidogenic capacity.

CEBPA profil antigène

Profil protéine

The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain promoters and enhancers. It can also form heterodimers with the related proteins CEBP-beta and CEBP-gamma. The encoded protein has been shown to bind to the promoter and modulate the expression of the gene encoding leptin, a protein that plays an important role in body weight homeostasis. Also, the encoded protein can interact with CDK2 and CDK4, thereby inhibiting these kinases and causing growth arrest in cultured cells.

Gene names and symbols associated with CEBPA

  • CCAAT/enhancer binding protein (C/EBP), alpha (CEBPA) anticorps
  • CCAAT/enhancer binding protein (C/EBP), alpha (Cebpa) anticorps
  • CCAAT/enhancer binding protein (C/EBP), alpha (cebpa) anticorps
  • CCAAT/enhancer-binding protein alpha-like (LOC100358602) anticorps
  • C/EBP anticorps
  • C/EBP-alpha anticorps
  • c/ebpa anticorps
  • C/EBP alpha anticorps
  • C/EBPalpha anticorps
  • cb1062 anticorps
  • CBF-A anticorps
  • cC/EBP anticorps
  • Cebp anticorps
  • DBPCEP anticorps
  • wu:fj20f03 anticorps
  • xC/EBP anticorps

Protein level used designations for CEBPA

CCAAT/enhancer-binding protein alpha , C/EBP alpha , CAAT/enhancer-binding protein DNA-binding protein , CAAT/enhancer-binding protein, DNA-binding protein , CCAAT/enhancer binding protein, alpha , chunp6777 , fj20f03 , c/EBP alpha , CCAAT/enhancer binding protein alpha

GENE ID SPECIES
1050 Homo sapiens
12606 Mus musculus
24252 Rattus norvegicus
140815 Danio rerio
379967 Xenopus laevis
281677 Bos taurus
427549 Gallus gallus
397307 Sus scrofa
100358602 Oryctolagus cuniculus
Fournisseurs de qualité sélectionnés pour anti-CEBPA (CEBPA) Anticorps
Avez-vous cherché autre chose?